Insider Trading activities of Invitrogen Corp insiders. , Part 3

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Invitrogen Corp since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Invitrogen Corp since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Invitrogen Corp since 2005. The reporting company's ticker symbol is IVGN. The reporting company's CIK number is 1073431.
The total value of stock buying since 2005 is $3,880,122.
The total value of stock sales since 2005 is $196,970,946.
The total value of stock option exercises since 2005 is $159,543,907.


Go to page:  1   2   3 

Table 2. Detailed insider stock purchases, sales, and option exercises of Invitrogen Corp insiders (IVGN) , Part 3
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2009-01-17 Levine Arnold J (Director) Option Ex 5,218 24.46 127,632
2008-12-05 Miller John L (President, Genetic Systems) Option Ex 30,000 .00 0
2008-11-30 Brust Bernd (Pres, Commercial Operations) Option Ex 5,500 .00 0
2008-11-30 Miller John L (President, Genetic Systems) Option Ex 5,500 .00 0
2008-11-30 Leddy Peter Michael (SVP, Global Human Resources) Option Ex 5,300 .00 0
2008-11-30 Hoffmeister David F (Chief Financial Officer) Option Ex 5,300 .00 0
2008-11-30 Barthelemy Nicolas (President, Cell Systems) Option Ex 5,300 .00 0
2008-11-30 Cottingham John A (Chief Legal Officer) Option Ex 5,300 .00 0
2008-11-18 Matricaria Ronald A (Director) Buy 11,700 24.69 288,873
2008-11-17 Matricaria Ronald A (Director) Buy 18,300 24.71 452,211
2008-11-14 Brust Bernd (SVP, Worldwide Sales) Option Ex 2,000 .00 0
2008-11-14 Leddy Peter Michael (SVP, Human Resources) Option Ex 2,000 .00 0
2008-11-14 Hoffmeister David F (Chief Financial Officer) Option Ex 9,000 .00 0
2008-11-14 Barthelemy Nicolas (SVP, Cell Culture Systems) Option Ex 5,000 .00 0
2008-11-14 Benchimol Claude (SVP, Advanced Genomic Systems) Option Ex 6,000 .00 0
2008-11-14 Lucier Gregory T (CEO) Buy 37,800 26.42 998,676
2008-11-14 Lucier Gregory T (CEO) Option Ex 12,000 .00 0
2008-11-14 Matricaria Ronald A (Director) Buy 10,000 26.24 262,400
2008-11-14 Cottingham John A (SVP, Gen Counsel & Secretary) Option Ex 3,000 .00 0
2008-07-05 Leddy Peter Michael (SVP, Human Resources) Option Ex 40,000 .00 0
2008-06-18 Uprichard David C (Director) Option Ex 1,200 36.18 43,416
2008-05-15 Brust Bernd (SVP, Worldwide Sales) Sale 6,800 92.77 630,370
2008-05-15 Brust Bernd (SVP, Worldwide Sales) Option Ex 7,200 82.28 520,745
2008-05-13 Brust Bernd (SVP - Worldwide Sales) Option Ex 500 .00 0
2008-05-13 Hoffmeister David F (Chief Financial Officer) Option Ex 4,500 .00 0
2008-05-13 Barthelemy Nicolas (SVP, Cell Culture Systems) Option Ex 3,000 .00 0
2008-05-13 Benchimol Claude (SVP, Research & Development) Option Ex 3,000 .00 0
2008-05-13 Lucier Gregory T (CEO) Option Ex 6,000 .00 0
2008-05-13 Cottingham John A (SVP, Gen Counsel & Secretary) Option Ex 1,500 .00 0
2008-05-12 Brust Bernd (SVP - Worldwide Sales) Sale 3,750 93.15 349,297
2008-05-12 Brust Bernd (SVP - Worldwide Sales) Option Ex 3,750 65.87 247,012
2008-05-01 Short Jay M Phd (Director) Sale 2,500 94.60 236,487
2008-05-01 Short Jay M Phd (Director) Option Ex 2,500 21.04 52,600
2008-04-25 Gibson Karen (Chief Information Officer) Sale 6,950 91.12 633,318
2008-04-25 Gibson Karen (Chief Information Officer) Option Ex 6,383 .00 0
2008-04-23 Barthelemy Nicolas (SVP, Cell Culture Systems) Sale 2,500 93.00 232,500
2008-04-23 Barthelemy Nicolas (SVP, Cell Culture Systems) Option Ex 2,500 .00 0
2008-03-27 Barthelemy Nicolas (SVP, Cell Culture Systems) Sale 2,500 85.62 214,050
2008-03-27 Barthelemy Nicolas (SVP, Cell Culture Systems) Option Ex 2,500 .00 0
2008-02-27 Gibson Karen (Chief Information Officer) Sale 14,250 87.00 1,239,750
2008-02-27 Gibson Karen (Chief Information Officer) Option Ex 14,250 63.51 905,017
2008-02-25 Gibson Karen (Chief Information Officer) Sale 1,221 85.20 104,029
2008-02-19 Uprichard David C (Director) Sale 200 86.69 17,338
2008-02-13 Uprichard David C (Director) Sale 300 86.34 25,902
2008-02-08 Short Jay M Phd (Director) Sale 13,800 88.12 1,216,056
2008-02-08 Short Jay M Phd (Director) Option Ex 27,846 45.68 1,271,893
2008-01-02 Brust Bernd (SVP - Worldwide Sales) Sale 5,875 92.20 541,675
2008-01-02 Brust Bernd (SVP - Worldwide Sales) Option Ex 5,875 56.59 332,466
2007-12-17 Hoffmeister David F (Chief Financial Officer) Sale 27,909 94.88 2,648,089
2007-12-13 Uprichard David C (Director) Sale 2,100 94.68 198,828
2007-12-13 Uprichard David C (Director) Option Ex 2,100 72.36 151,956
2007-12-11 Benchimol Claude (SVP, Research & Development) Option Ex 6,804 58.76 399,803
2007-12-11 Lucier Gregory T (CEO) Sale 65,676 94.32 6,209,882
2007-12-11 Lucier Gregory T (CEO) Option Ex 65,676 38.01 2,496,344
2007-12-10 Lucier Gregory T (CEO) Sale 105,448 97.03 10,326,844
2007-12-10 Lucier Gregory T (CEO) Option Ex 105,648 38.01 4,015,680
2007-12-07 Brust Bernd (SVP - Worldwide Sales) Sale 14,063 98.14 1,380,114
2007-12-07 Brust Bernd (SVP - Worldwide Sales) Option Ex 14,063 76.24 1,072,163
2007-12-06 Benchimol Claude (SVP, Research & Development) Sale 108,186 97.48 10,545,430
2007-12-06 Benchimol Claude (SVP, Research & Development) Option Ex 93,196 58.76 5,476,196
2007-12-05 Cottingham John A (SVP, Gen Counsel & Secretary) Sale 15,000 96.37 1,445,550
2007-12-05 Cottingham John A (SVP, Gen Counsel & Secretary) Option Ex 15,000 45.64 684,600
2007-11-30 Brust Bernd (SVP - Worldwide Sales) Sale 5,625 96.54 543,065
2007-11-30 Brust Bernd (SVP - Worldwide Sales) Option Ex 5,625 65.94 370,912
2007-11-26 Barthelemy Nicolas (SVP, Cell Culture Systems) Sale 13,579 95.00 1,290,005
2007-11-26 Barthelemy Nicolas (SVP, Cell Culture Systems) Option Ex 13,579 73.60 999,414
2007-11-19 Benchimol Claude (SVP, Research & Development) Sale 1,031 91.40 94,233
2007-11-16 Lucier Gregory T (CEO) Sale 400 90.07 36,028
2007-11-15 Barthelemy Nicolas (SVP, Cell Culture Systems) Sale 1,031 90.61 93,418
2007-11-14 Brust Bernd (SVP - Worldwide Sales) Sale 1,250 88.69 110,862
2007-11-14 Brust Bernd (SVP - Worldwide Sales) Option Ex 1,250 64.51 80,637
2007-11-14 Barthelemy Nicolas (SVP, Cell Culture Systems) Sale 2,500 90.00 225,000
2007-11-14 Barthelemy Nicolas (SVP, Cell Culture Systems) Option Ex 2,500 64.51 161,275
2007-11-12 Barthelemy Nicolas (SVP, Cell Culture Systems) Sale 3,250 90.00 292,500
2007-11-12 Barthelemy Nicolas (SVP, Cell Culture Systems) Option Ex 5,150 31.26 203,157
2007-11-12 Gibson Karen (Chief Information Officer) Option Ex 1,900 .00 0
2007-11-12 Benchimol Claude (SVP - R&D) Option Ex 1,900 .00 0
2007-11-12 Lucier Gregory T (Chairman & CEO) Option Ex 6,600 .00 0
2007-11-12 Cottingham John A (SVP, Gen Counsel & Secretary) Option Ex 2,000 .00 0
2007-11-07 Grimm Donald W (Director) Sale 18,100 91.00 1,646,948
2007-11-07 Grimm Donald W (Director) Option Ex 21,900 79.33 1,514,197
2007-11-01 Short Jay M Phd (Director) Sale 3,500 89.29 312,515
2007-11-01 Short Jay M Phd (Director) Option Ex 3,500 12.00 42,000
2007-10-31 Barthelemy Nicolas (SVP, Cell Culture Systems) Sale 22,268 88.54 1,971,541
2007-10-31 Barthelemy Nicolas (SVP, Cell Culture Systems) Option Ex 22,268 66.92 1,490,285
2007-10-31 Lucier Gregory T (Chairman & CEO) Sale 196,250 87.49 17,138,201
2007-10-31 Lucier Gregory T (Chairman & CEO) Option Ex 196,250 38.01 7,459,462
2007-10-25 Barthelemy Nicolas (SVP, Cell Culture Systems) Option Ex 2,842 70.34 199,906
2007-10-18 Barthelemy Nicolas (SVP, Cell Culture Systems) Sale 5,640 84.52 476,692
2007-10-18 Barthelemy Nicolas (SVP, Cell Culture Systems) Option Ex 5,640 70.34 396,717
2007-10-18 Lucier Gregory T (Chairman & CEO) Sale 3,750 85.00 318,750
2007-10-18 Lucier Gregory T (Chairman & CEO) Option Ex 3,750 38.01 142,537
2007-10-18 Cottingham John A (SVP, Gen Counsel & Secretary) Sale 10,000 84.52 845,200
2007-10-18 Cottingham John A (SVP, Gen Counsel & Secretary) Option Ex 10,000 56.86 568,600
2007-10-15 Hoffmeister David F (Chief Financial Officer) Option Ex 50,000 .00 0
2007-10-05 Brust Bernd (SVP - Worldwide Sales) Sale 1,250 84.00 105,000
2007-10-05 Brust Bernd (SVP - Worldwide Sales) Option Ex 1,250 64.51 80,637
2007-09-06 Barthelemy Nicolas (SVP, Cell Culture Systems) Option Ex 1,421 70.34 99,953
2007-09-05 Cottingham John A (SVP, Gen Counsel & Secretary) Sale 11,500 80.00 920,000
2007-09-05 Cottingham John A (SVP, Gen Counsel & Secretary) Option Ex 11,500 40.08 460,862
2007-09-05 Thompson John D (SVP, Corporate Development) Sale 27,813 80.00 2,225,040
2007-09-04 Benchimol Claude (SVP, Research & Development) Option Ex 12,500 .00 0
2007-08-24 Richard Kelli (Chief Accounting Officer) Sale 937 78.43 73,488
2007-08-17 Uprichard David C (Director) Option Ex 400 72.36 28,944
2007-08-06 Brust Bernd (SVP - Worldwide Sales) Sale 16,250 78.37 1,273,497
2007-07-20 Short Jay M Phd (Director) Option Ex 2,000 3.80 7,600
2007-07-10 Barthelemy Nicolas (SVP, Cell Culture Systems) Sale 7,250 75.00 543,750
2007-06-15 Barthelemy Nicolas (SVP, Cell Culture Systems) Sale 3,250 75.00 243,750
2007-06-15 Barthelemy Nicolas (SVP, Cell Culture Systems) Option Ex 3,250 62.51 203,157
2007-06-15 Uprichard David C (Director) Sale 500 74.53 37,265
2007-06-13 Cottingham John A (SVP, Gen Counsel & Secretary) Sale 19,635 74.01 1,453,186
2007-06-13 Cottingham John A (SVP, Gen Counsel & Secretary) Option Ex 14,300 34.51 493,493
2007-06-11 Barthelemy Nicolas (SVP, Cell Culture Systems) Sale 437 74.00 32,338
2007-05-15 Barthelemy Nicolas (SVP Cell Culture Systems) Sale 1,617 71.84 116,173
2007-05-14 Benchimol Claude (SVP R&D) Option Ex 2,500 .00 0
2007-05-14 Cottingham John A (SVP General Counsel & Sec.) Option Ex 2,500 .00 0
2007-05-14 Thompson John D (SVP Corporate Development) Option Ex 2,500 .00 0
2007-05-12 Lucier Gregory T (Chairman & CEO) Option Ex 9,000 .00 0
2007-02-28 Radak John Matthew (VP Finance & Accounting) Sale 761 64.28 48,917
2007-02-28 Radak John Matthew (VP Finance & Accounting) Option Ex 761 29.70 22,601
2007-02-22 Lorimier Bradley G (Director) Sale 5,900 66.20 390,580
2007-02-22 Lorimier Bradley G (Director) Option Ex 10,000 12.00 120,000
2007-02-14 Bulkley Benjamin (Sr. VP Global Commercial Ops) Sale 98,374 66.18 6,509,997
2007-02-14 Bulkley Benjamin (Sr. VP Global Commercial Ops) Option Ex 98,374 62.59 6,157,327
2006-08-15 Uprichard David C (Director) Buy 100 59.85 5,985
2006-08-11 Uprichard David C (Director) Buy 200 58.97 11,794
2006-08-10 Uprichard David C (Director) Buy 200 58.60 11,720
2006-08-10 Reynolds W Ann (Director) Buy 808 58.20 47,025
2006-08-07 Barthelemy Nicolas (SVP BioProduction Sys & Svcs) Buy 2,700 56.24 151,848
2006-06-06 Uprichard David C (Director) Buy 100 63.26 6,326
2006-05-30 Lucier Gregory T (Chairman & CEO) Buy 1,000 64.18 64,180
2006-05-26 Lucier Gregory T (Chairman & CEO) Buy 2,000 64.10 128,199
2006-05-15 Radak John Matthew (VP Finance & Accounting) Sale 394 67.05 26,417
2006-03-13 Barthelemy Nicolas (Svp) Sale 5,000 69.73 348,630
2005-11-16 Hoffmeister David F (Chief Financial Officer) Buy 1,530 65.02 99,485
2005-08-05 Radak John Matthew (Accounting) Sale 262 85.43 22,382
2005-05-31 Lucier Gregory T (CEO) Sale 16,613 79.43 1,319,520
2005-05-18 Grimm Donald W (Director) Sale 9,000 79.00 711,000
2005-05-18 Grimm Donald W (Director) Option Ex 10,000 12.00 120,000
2005-03-11 Uprichard David C (Director) Buy 500 71.08 35,540
2005-03-09 Uprichard David C (Director) Buy 500 71.08 35,540
2005-02-23 Reynolds W Ann (Director) Buy 1,200 68.74 82,488
Go to page:  1   2   3 

Insider trading activities including stock purchases, stock sales, and option exercises of IVGN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Invitrogen Corp (symbol IVGN, CIK number 1073431) see the Securities and Exchange Commission (SEC) website.